TTC Oncology
MN - MinneapolisBiotechnology
Focus: Small Molecule for Breast Cancer
TTC Oncology is a life sciences company focused on Small Molecule for Breast Cancer.
Profile data last refreshed Yesterday
Open Jobs
0
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TTC-352
Metastatic ER+ Breast CancerClinical Trials (1)
NCT03201913Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy
Phase 1Help build intelligence for TTC Oncology
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.